123 related articles for article (PubMed ID: 3275339)
21. [Long-term effect on preoperative ulnaris arterial intubation chemotherapy in treatment of stage III breast cancer].
Huang C; Zhang X; Lu H; Wu X; Guan G; Wang C; Zhou Y; Zhang J
Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):412-4. PubMed ID: 11832070
[TBL] [Abstract][Full Text] [Related]
22. Intensification of adjuvant chemotherapy in patients with primary breast cancer and positive axillary nodes.
Elias EG
Md Med J; 1990 Dec; 39(12):1072-3. PubMed ID: 2266815
[No Abstract] [Full Text] [Related]
23. Adjuvant therapy in breast cancer.
Robert NJ
Obstet Gynecol Clin North Am; 1994 Dec; 21(4):693-707. PubMed ID: 7731642
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer: metastatic.
Johnston S; Stebbing J
Clin Evid; 2002 Jun; (7):1579-602. PubMed ID: 12230774
[No Abstract] [Full Text] [Related]
25. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.
Harlan LC; Clegg LX; Abrams J; Stevens JL; Ballard-Barbash R
J Clin Oncol; 2006 Feb; 24(6):872-7. PubMed ID: 16484696
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant systemic therapy of breast cancer.
Lippman ME
Important Adv Oncol; 1985; ():254-72. PubMed ID: 3916744
[No Abstract] [Full Text] [Related]
27. Adjuvant systemic therapy for breast cancer.
Harris DT
Semin Oncol; 1995 Dec; 22(6):553-70. PubMed ID: 8539632
[No Abstract] [Full Text] [Related]
28. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
[TBL] [Abstract][Full Text] [Related]
29. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
[TBL] [Abstract][Full Text] [Related]
30. Combined modality treatment of stage III and inflammatory breast cancer. M.D. Anderson Cancer Center experience.
Buzdar AU; Singletary SE; Booser DJ; Frye DK; Wasaff B; Hortobagyi GN
Surg Oncol Clin N Am; 1995 Oct; 4(4):715-34. PubMed ID: 8535907
[TBL] [Abstract][Full Text] [Related]
31. [Adjuvant mono- and polychemotherapy in breast cancer (a randomized study)].
Semiglazov VF; Bavli IaL; Moiseenko VM; Rzhankov SV; Migmanova NSh
Vopr Onkol; 1985; 31(12):29-35. PubMed ID: 3936272
[TBL] [Abstract][Full Text] [Related]
32. [Effectiveness of adjuvant systemic therapy in organ preserving treatment of pT1-2N0M0 breast cancer].
Semiglazov VF; Kanaev SV; Bugrova IL; Vlasov AN
Vopr Onkol; 1999; 45(5):516-9. PubMed ID: 10629708
[TBL] [Abstract][Full Text] [Related]
33. [General evaluation of adjuvant chemotherapy trials in breast cancer (excluding the Milan trial)].
Gest J
Bull Cancer; 1984; 71(4):336-44. PubMed ID: 6388672
[TBL] [Abstract][Full Text] [Related]
34. [Experience with an adjuvant chemotherapy program in stage II breast cancer].
Morelli M; Valle M; Balducci D; Nardi M; Serafini D; Bontempi G
Minerva Ginecol; 1984 Oct; 36(10):619-22. PubMed ID: 6527815
[No Abstract] [Full Text] [Related]
35. Management of locally advanced breast cancer. Mini-review.
Franceschini G; Terribile D; Fabbri C; Magno S; D'Alba P; Chiesa F; Di Leone A; Masetti R
Minerva Chir; 2007 Aug; 62(4):249-55. PubMed ID: 17641585
[TBL] [Abstract][Full Text] [Related]
36. [Response evaluation with mammography and ultrasound].
Junkermann H; Schmid H; Sinn HP; Wallwiener D
Zentralbl Gynakol; 1996; 118(10):572-3. PubMed ID: 8999712
[No Abstract] [Full Text] [Related]
37. Economic evaluation of high-dose chemotherapy and bone marrow transplantation for patients with breast cancer of stage II or IIIA with more than 10 positive lymph nodes at surgical excision.
Schulman KA; Glick HA
J Natl Cancer Inst Monogr; 1995; (19):45-50. PubMed ID: 7577205
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
Botti C; Vici P; Lopez M; Scinto AF; Cognetti F; Cavaliere R
J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant chemotherapy in stage III breast cancer.
Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
[TBL] [Abstract][Full Text] [Related]
40. [Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval].
Zielinski CC; Kuzmits R; Kubista E; Salzer H; Staffen A; Aiginger P; Spona J
Wien Klin Wochenschr; 1985 May; 97(11):493-7. PubMed ID: 4013343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
